FDA Prepares CLIA Guidances, Will Take Over CLIA Reviews In November
This article was originally published in The Gray Sheet
Executive Summary
FDA will take the lead in reviewing Clinical Laboratory Improvement Act waiver applications and protocols, as well as complexity categorizations, starting Nov. 1.